ACAT1 and prostate carcinoma: Since ACAT1 negatively regulates the MAPK signaling pathway [99], Peck and Shulze [173] concluded that SIRT5 promotes the proliferation, invasion, and migration of prostate cancer via the downregulation of ACAT1 protein levels.